Gene expression profiling of lichenoid dermatitis immune‐related adverse event from immune checkpoint inhibitors reveals increased CD14+ and CD16+ monocytes driving an innate immune response.

Saved in:
Bibliographic Details
Title: Gene expression profiling of lichenoid dermatitis immune‐related adverse event from immune checkpoint inhibitors reveals increased CD14+ and CD16+ monocytes driving an innate immune response.
Authors: Curry, Jonathan L.1,2,3 (AUTHOR) jlcurry@mdanderson.org, Reuben, Alexandre4 (AUTHOR), Szczepaniak‐Sloane, Robert5 (AUTHOR), Ning, Jing6 (AUTHOR), Milton, Denái R.6 (AUTHOR), Lee, Chi H.6 (AUTHOR), Hudgens, Courtney3 (AUTHOR), George, Saira2 (AUTHOR), Torres‐Cabala, Carlos1,2 (AUTHOR), Johnson, Daniel7 (AUTHOR), Subramanya, Sandesh3 (AUTHOR), Wargo, Jennifer A.5 (AUTHOR), Mudaliar, Kumaran8 (AUTHOR), Wistuba, Ignacio I.3 (AUTHOR), Prieto, Victor G.1,2 (AUTHOR), Diab, Adi7 (AUTHOR), Tetzlaff, Michael T.1,3 (AUTHOR)
Source: Journal of Cutaneous Pathology. Sep2019, Vol. 46 Issue 9, p627-636. 10p. 3 Diagrams, 4 Charts, 2 Graphs.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:03036987
DOI:10.1111/cup.13454